Australia markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.47+0.13 (+0.19%)
At close: 04:00PM EST
68.46 -0.01 (-0.01%)
After hours: 07:16PM EST
Full screen
Trade prices are not sourced from all markets
Previous close68.34
Open68.18
Bid68.25 x 800
Ask68.42 x 1100
Day's range68.04 - 68.72
52-week range52.65 - 71.70
Volume3,559,611
Avg. volume6,184,724
Market cap213.837B
Beta (5Y monthly)0.17
PE ratio (TTM)106.98
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.45 (2.19%)
Ex-dividend date11 Aug 2022
1y target estN/A
  • Zacks

    Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal

    Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.

  • Motley Fool

    2 Stocks That Could Surprise Investors in 2023

    The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions. A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS). AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be.

  • Motley Fool

    Why Shares of Compugen Rose 16.5% on Wednesday

    Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday. The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20. The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.